HK1211290A1 - Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases - Google Patents
Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseasesInfo
- Publication number
- HK1211290A1 HK1211290A1 HK15112117.6A HK15112117A HK1211290A1 HK 1211290 A1 HK1211290 A1 HK 1211290A1 HK 15112117 A HK15112117 A HK 15112117A HK 1211290 A1 HK1211290 A1 HK 1211290A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- substitued
- heterocycle
- treatment
- methods
- viral diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2013/000038 WO2014110687A1 (fr) | 2013-01-16 | 2013-01-16 | Composés tétracycliques substitués par thiazolyle et leurs procédés d'utilisation pour le traitement de maladies virales |
PCT/CN2013/001676 WO2014110705A1 (fr) | 2013-01-16 | 2013-12-31 | Composés tétracycliques substitués par un hétérocycle et procédés pour les utiliser pour le traitement de maladies virales |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1211290A1 true HK1211290A1 (en) | 2016-05-20 |
Family
ID=51208906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15112117.6A HK1211290A1 (en) | 2013-01-16 | 2015-12-08 | Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases |
Country Status (26)
Country | Link |
---|---|
US (1) | US9555038B2 (fr) |
EP (1) | EP2945952B1 (fr) |
JP (3) | JP6093451B2 (fr) |
KR (1) | KR101748974B1 (fr) |
CN (1) | CN105073755B (fr) |
AP (1) | AP2015008625A0 (fr) |
AR (1) | AR094496A1 (fr) |
AU (1) | AU2013374112B2 (fr) |
BR (1) | BR112015016325A2 (fr) |
CA (1) | CA2898049C (fr) |
CL (1) | CL2015001971A1 (fr) |
CR (1) | CR20150378A (fr) |
DO (1) | DOP2015000169A (fr) |
EA (1) | EA030554B1 (fr) |
EC (1) | ECSP15035530A (fr) |
HK (1) | HK1211290A1 (fr) |
IL (1) | IL239832A0 (fr) |
MA (1) | MA38315B1 (fr) |
MD (1) | MD20150075A2 (fr) |
MX (1) | MX356203B (fr) |
PE (1) | PE20151892A1 (fr) |
PH (1) | PH12015501560A1 (fr) |
SG (1) | SG11201505536RA (fr) |
TN (1) | TN2015000293A1 (fr) |
TW (1) | TW201441231A (fr) |
WO (2) | WO2014110687A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014110687A1 (fr) * | 2013-01-16 | 2014-07-24 | Merck Sharp & Dohme Corp. | Composés tétracycliques substitués par thiazolyle et leurs procédés d'utilisation pour le traitement de maladies virales |
WO2016196932A1 (fr) * | 2015-06-04 | 2016-12-08 | Merck Sharp & Dohme Corp. | Procédé de préparation de composés hétérocycliques tétracycliques substitués |
US20180228826A1 (en) * | 2015-08-04 | 2018-08-16 | Merck Sharp & Dohme Corp. | Fixed-dose combinations of antiviral compounds |
US20180228828A1 (en) * | 2015-08-04 | 2018-08-16 | Merck Sharp & Dohme Corp. | Fixed-dose combinations of antiviral compounds |
WO2017112531A1 (fr) * | 2015-12-21 | 2017-06-29 | Merck Sharp & Dohme Corp. | Composés hétérocycliques contenant un silane et méthodes d'utilisation desdits composés pour traiter les maladies virales |
WO2017181383A1 (fr) | 2016-04-21 | 2017-10-26 | Merck Sharp & Dohme Corp. | Inhibiteurs du virus de l'hépatite c |
WO2017219808A1 (fr) * | 2016-06-21 | 2017-12-28 | 浙江柏拉阿图医药科技有限公司 | Inhibiteur du virus de l'hépatite c et application |
WO2018032468A1 (fr) * | 2016-08-18 | 2018-02-22 | Merck Sharp & Dohme Corp. | Composés tétracycliques substitués par hétérocycles et leurs procédés d'utilisation pour le traitement de maladies virales |
WO2018032467A1 (fr) * | 2016-08-18 | 2018-02-22 | Merck Sharp & Dohme Corp. | Composés tétracycliques substitués par chromane et leurs utilisations dans le traitement de maladies virales |
CN109206396B (zh) * | 2017-07-05 | 2023-03-28 | 上海迪赛诺化学制药有限公司 | 2-c-甲基-4,5-o-(1-甲基乙烯基)-d-阿拉伯糖酸乙酯的制备方法 |
CN109232612A (zh) * | 2017-07-11 | 2019-01-18 | 周龙兴 | 抑制丙肝病毒的化合物、药物组合物及其用途 |
EP3870183A4 (fr) * | 2018-10-26 | 2022-07-20 | Merck Sharp & Dohme Corp. | Formulations de composés antiviraux |
TW202317145A (zh) * | 2021-06-17 | 2023-05-01 | 美商亞堤製藥公司 | 有利之抗hcv組合療法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3927630B2 (ja) | 1996-09-27 | 2007-06-13 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ウイルス感染症の予防・治療剤 |
US7547702B2 (en) | 2000-09-20 | 2009-06-16 | Ortho-Mcneil Pharmaceutical, Inc. | 4-amino-quinazolines |
EP1644385B1 (fr) | 2003-07-10 | 2007-08-29 | Takeda Cambridge Limited | Composes de silicium et leur utilisation |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
PT1719773E (pt) | 2004-02-24 | 2009-06-03 | Japan Tobacco Inc | Compostos heterotetracíclicos fundidos e a sua utilização como inibidores da polimerase do hcv |
WO2007084413A2 (fr) | 2004-07-14 | 2007-07-26 | Ptc Therapeutics, Inc. | Procedes de traitement de l’hepatite c |
US7153848B2 (en) | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
CA2585113A1 (fr) | 2004-10-26 | 2006-05-04 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Derives d'indole tetracycliques utilises comme agents antiviraux |
US7894996B2 (en) | 2005-02-28 | 2011-02-22 | The Rockefeller University | Structure of the hepatitis C NS5A protein |
US7994360B2 (en) | 2005-05-16 | 2011-08-09 | Xtl Biopharmaceuticals Ltd. | Benzofuran compounds |
US20110104109A1 (en) | 2005-07-13 | 2011-05-05 | Frank Bennett | Tetracyclic indole derivatives and their use for treating or preventing viral infections |
CN101213190A (zh) | 2005-07-14 | 2008-07-02 | Irm责任有限公司 | 用作tpo模拟物的化合物和组合物 |
US7473784B2 (en) | 2005-08-01 | 2009-01-06 | Bristol-Myers Squibb Company | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
FR2894963A1 (fr) | 2005-12-16 | 2007-06-22 | Inst Nat Sante Rech Med | Nouveaux composes interagissant avec pea-15 |
US7745636B2 (en) | 2006-08-11 | 2010-06-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US20110130361A1 (en) | 2007-08-09 | 2011-06-02 | Jonathan Grimm | Silicon derivatives as histone deacetylase inhibitors |
US7642251B2 (en) | 2007-08-09 | 2010-01-05 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
AU2008287421A1 (en) | 2007-08-10 | 2009-02-19 | Glaxosmithkline Llc | Nitrogen containing bicyclic chemical entities for treating viral infections |
US7704992B2 (en) | 2008-02-13 | 2010-04-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
JP5312486B2 (ja) | 2008-02-13 | 2013-10-09 | ブリストル−マイヤーズ スクイブ カンパニー | C型肝炎ウイルス阻害剤 |
PL2310095T3 (pl) | 2008-07-22 | 2013-03-29 | Msd Italia Srl | Makrocykliczne związki chinoksaliny jako inhibitory proteazy NS3 HCV |
JP5655568B2 (ja) | 2008-10-09 | 2015-01-21 | コニカミノルタ株式会社 | 有機光電変換素子、太陽電池及び光センサアレイ |
WO2010062821A1 (fr) | 2008-11-28 | 2010-06-03 | Glaxosmithkline Llc | Composés antiviraux, compositions, et procédés d’utilisation |
PE20150939A1 (es) | 2008-12-03 | 2015-07-19 | Presidio Pharmaceuticals Inc | Inhibidores de la proteina no estructural 5a del virus de la hepatitis c |
EP2411038B1 (fr) | 2009-03-27 | 2016-12-28 | Van Andel Research Institute | Peptides de l'hormone parathyroïdienne et peptides de la protéine apparentée à l'hormone parathyroïdienne ainsi que des procédés d'utilisation |
BRPI1012282A2 (pt) | 2009-03-27 | 2015-09-22 | Presidio Pharmaceuticals Inc | inibidores de anel fundidos da hepatite c. |
EA020898B1 (ru) * | 2009-03-27 | 2015-02-27 | Мерк Шарп Энд Домэ Корп. | Ингибиторы репликации вируса гепатита c |
JP2012528194A (ja) | 2009-05-29 | 2012-11-12 | メルク・シャープ・アンド・ドーム・コーポレーション | C型肝炎などの疾患を処置するための3つの整列型アリール部分で構成された抗菌性化合物 |
US8221737B2 (en) | 2009-06-16 | 2012-07-17 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8377980B2 (en) | 2009-12-16 | 2013-02-19 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US20130156731A1 (en) | 2009-12-22 | 2013-06-20 | Kevin X. Chen | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas |
MA34147B1 (fr) | 2010-03-09 | 2013-04-03 | Merck Sharp & Dohme | Composes tricycliques fusionnes de silyle et leurs methodes d'utilisation dans le cadre du traitement de maladies virales |
JP2013538831A (ja) * | 2010-09-29 | 2013-10-17 | メルク・シャープ・エンド・ドーム・コーポレイション | C型肝炎ウィルス感染治療のための四環式インドール誘導体 |
WO2012040923A1 (fr) * | 2010-09-29 | 2012-04-05 | Merck Sharp & Dohme Corp. | Dérivés d'indoles tétracycliques et leurs méthodes d'utilisation pour le traitement de maladies virales |
EP2621501A4 (fr) * | 2010-09-29 | 2014-04-09 | Merck Sharp & Dohme | Dérives hétérocycliques polycycliques et méthodes pour leur utilisation dans le traitement de maladies virales |
WO2014110687A1 (fr) * | 2013-01-16 | 2014-07-24 | Merck Sharp & Dohme Corp. | Composés tétracycliques substitués par thiazolyle et leurs procédés d'utilisation pour le traitement de maladies virales |
WO2014110688A1 (fr) * | 2013-01-16 | 2014-07-24 | Merck Sharp & Dohme Corp. | Composés tétracycliques à substitution thiophène et leurs procédés d'utilisation pour le traitement des maladies virales |
-
2013
- 2013-01-16 WO PCT/CN2013/000038 patent/WO2014110687A1/fr active Application Filing
- 2013-12-31 WO PCT/CN2013/001676 patent/WO2014110705A1/fr active Application Filing
- 2013-12-31 JP JP2015551946A patent/JP6093451B2/ja not_active Expired - Fee Related
- 2013-12-31 MA MA38315A patent/MA38315B1/fr unknown
- 2013-12-31 CN CN201380074735.2A patent/CN105073755B/zh not_active Expired - Fee Related
- 2013-12-31 US US14/761,256 patent/US9555038B2/en active Active
- 2013-12-31 AP AP2015008625A patent/AP2015008625A0/xx unknown
- 2013-12-31 MX MX2015009225A patent/MX356203B/es active IP Right Grant
- 2013-12-31 EP EP13871363.1A patent/EP2945952B1/fr active Active
- 2013-12-31 MD MDA20150075A patent/MD20150075A2/ro not_active Application Discontinuation
- 2013-12-31 PE PE2015001352A patent/PE20151892A1/es not_active Application Discontinuation
- 2013-12-31 BR BR112015016325A patent/BR112015016325A2/pt not_active Application Discontinuation
- 2013-12-31 SG SG11201505536RA patent/SG11201505536RA/en unknown
- 2013-12-31 EA EA201591328A patent/EA030554B1/ru not_active IP Right Cessation
- 2013-12-31 KR KR1020157021818A patent/KR101748974B1/ko active IP Right Grant
- 2013-12-31 CA CA2898049A patent/CA2898049C/fr not_active Expired - Fee Related
- 2013-12-31 AU AU2013374112A patent/AU2013374112B2/en not_active Ceased
-
2014
- 2014-01-16 TW TW103101674A patent/TW201441231A/zh unknown
- 2014-01-16 AR ARP140100153A patent/AR094496A1/es unknown
-
2015
- 2015-06-29 TN TNP2015000293A patent/TN2015000293A1/fr unknown
- 2015-07-08 IL IL239832A patent/IL239832A0/en unknown
- 2015-07-13 CL CL2015001971A patent/CL2015001971A1/es unknown
- 2015-07-13 PH PH12015501560A patent/PH12015501560A1/en unknown
- 2015-07-16 DO DO2015000169A patent/DOP2015000169A/es unknown
- 2015-07-16 CR CR20150378A patent/CR20150378A/es unknown
- 2015-08-17 EC ECIEPI201535530A patent/ECSP15035530A/es unknown
- 2015-12-08 HK HK15112117.6A patent/HK1211290A1/xx unknown
-
2016
- 2016-11-07 JP JP2016217169A patent/JP6148779B2/ja not_active Expired - Fee Related
- 2016-11-18 JP JP2016225137A patent/JP6417380B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211290A1 (en) | Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases | |
HK1207636A1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
ZA201602839B (en) | Methods of using interleukin-10 for treating diseases and disorders | |
HK1215681A1 (zh) | 使用白細胞介素- 治療疾病和病症的方法 | |
HK1216421A1 (zh) | 用於治療病毒感染的治療化合物 | |
HK1220418A1 (zh) | 治療呼吸系統疾病的方法及為此而製的製劑 | |
HK1210463A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
HK1222552A1 (zh) | 索布替羅用於治療髓鞘形成疾病 | |
EP2753618A4 (fr) | Dérivés benzofuranes substitués par un hétérocycle et leurs procédés d'utilisation pour le traitement de maladies virales | |
EP3010512A4 (fr) | Dérivés de nucléosides cycliques à substitution phosphonate et leurs méthodes d'utilisation pour le traitement de maladies virales | |
EP2685984A4 (fr) | Dérivés tétracycliques de xanthène et leurs méthodes d'utilisation en vue du traitement de maladies virales | |
EP2999474A4 (fr) | Thérapeutique et procédé d'utilisation | |
EP2958936A4 (fr) | Méthodes et compositions pour le traitement de la maladie de forbes-cori | |
IL231217A0 (en) | Tetracyclic heterocyclic compounds and methods of using them in the treatment of viral diseases | |
EP2753611A4 (fr) | Composés benzofuranes substitués et leurs procédés d'utilisation pour le traitement de maladies virales | |
EP2943189A4 (fr) | Procédés et compositions pour le traitement de maladies de démyélinisation | |
EP2953456A4 (fr) | Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de l'hépatite c | |
EP2945953A4 (fr) | Composés tétracycliques à substitution thiophène et leurs méhodes d'utilisation pour le traitement de maladies virales | |
HK1226308A1 (zh) | 使用白細胞介素-10治療疾病和病症的方法 | |
HK1225385A1 (zh) | 用於治療呼吸病的雜芳基衍生物 | |
EP3013834A4 (fr) | Composés benzofuranes substitués et leurs méthodes d'utilisation pour le traitement de maladies virales | |
EP2953462A4 (fr) | Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de l'hépatite c | |
EP3013334A4 (fr) | Composés benzofuranes substitués et leurs méthodes d'utilisation pour le traitement de maladies virales | |
HK1216881A1 (zh) | 用於治療病毒感染和另外的疾病的吡啶酮衍生物 | |
EP3083634A4 (fr) | Composés hétérocycliques tétracycliques fusionnés et leurs méthodes d'utilisation pour le traitement de maladies virales |